<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04194723</url>
  </required_header>
  <id_info>
    <org_study_id>CREC 2016.194T</org_study_id>
    <nct_id>NCT04194723</nct_id>
  </id_info>
  <brief_title>Antireflux Mucosectomy (ARMS) for Treatment of Gastroesophageal Reflux</brief_title>
  <acronym>ARMS</acronym>
  <official_title>Phase II Clinical Study on the Safety and Efficacy of Antireflux Mucosectomy (ARMS) for Treatment of Gastroesophageal Reflux</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase II clinical study to investigate the safety and efficacy of endoscopic
      antireflux mucosectomy (ARMS) for treatment of GERD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study is to establish the clinical efficacy and safety of ARMS for
      treatment of GERD.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in Gastro Esophageal Reflux symptoms</measure>
    <time_frame>3 months</time_frame>
    <description>GERD symptoms evidence by the improvement in the Gastroesophageal Reflux Quality of Life (QoL) of ≥50% compared to the baseline off Proton Pump Inhibitors (PPI) value 3 months after the procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical Success</measure>
    <time_frame>1 day</time_frame>
    <description>Success in resection of mucosa at cardia by ARMS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 hour pH study post ARMS</measure>
    <time_frame>3 and 12 months</time_frame>
    <description>24 hour pH study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High resolution Manometry</measure>
    <time_frame>3 and 12 months</time_frame>
    <description>HRM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastroesophageal junction classified by Hill's classification</measure>
    <time_frame>3 and 12 months</time_frame>
    <description>endoscopic assessment of Gastroesophageal junction</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Gastro Esophageal Reflux</condition>
  <arm_group>
    <arm_group_label>Antireflux Mucosectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Antireflux mucosectomy targeted at resection of gastric cardia muocsa to induce fibrosis and improve on the flap value over the gastroesophageal junction</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Antireflux Mucosectomy</intervention_name>
    <description>ARMS aimed at resection of mucosa at gastric cardia to induce fibrosis and tighten the gastroesophageal junction and reduce acid reflux</description>
    <arm_group_label>Antireflux Mucosectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with typical symptoms of GERD with symptomatic response to PPI therapy for ≥
             3 months

          2. Hill's grade II and III of the gastroesophageal junction

          3. One of the following abnormalities in the objective assessment 3.1. Excessive acid
             exposure at the distal esophagus evidenced by 24 hour pH tests using % total time pH &lt;
             4 and / or DeMeester score 3.2. Endoscopic evidence of LA classes A,B,C or D
             esophagitis 3.3. Defective LES assessed by HRM with resting pressure of &lt; 6mmHg or
             total length of less than 4cm or abdominal length of less than 2cm

        Exclusion Criteria:

          1. Age &gt; 70 yrs of &lt; 18 yrs

          2. Pregnancy

          3. Any type of Hiatus hernia

          4. Patients with underlying malignancy

          5. ASA above grade III
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philip Wai Yan Chiu, MD, FRCSEd</last_name>
    <phone>+85235053952</phone>
    <email>philipchiu@surgery.cuhk.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Man Yee Yung</last_name>
    <phone>+85235052956</phone>
    <email>myyung@surgery.cuhk.edu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Combined Endoscopy Center, Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>00000</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Chiu, MD</last_name>
      <phone>85226322627</phone>
      <email>philipchiu@surgery.cuhk.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Man Yee Yung</last_name>
      <phone>+85235052956</phone>
      <email>myyung@surgery.cuhk.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Philip WY Chiu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 10, 2019</study_first_submitted>
  <study_first_submitted_qc>December 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2019</study_first_posted>
  <last_update_submitted>December 10, 2019</last_update_submitted>
  <last_update_submitted_qc>December 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Philip Wai Yan Chiu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Antireflux Mucosectomy</keyword>
  <keyword>GERD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

